Indefinite-Lived Research and Development Assets
Boston Scientific Indefinite-Lived Research and Development Assets decreased by 5.3% to $770.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 719.1%, from $94.00M to $770.00M. Over 5 years (FY 2020 to FY 2025), Indefinite-Lived Research and Development Assets shows an upward trend with a 16.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
Detailed definition
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Peer comparison
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
indefinite_lived_rd_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $330.00M | $374.00M | $246.00M | $246.00M | $232.00M | $232.00M | $232.00M | $232.00M | $174.00M | $174.00M | $174.00M | $174.00M | $214.00M | $94.00M | $94.00M | $94.00M | $813.00M | $813.00M | $813.00M | $770.00M |
| QoQ Change | — | +13.3% | -34.2% | +0.0% | -5.7% | +0.0% | +0.0% | +0.0% | -25.0% | +0.0% | +0.0% | +0.0% | +23.0% | -56.1% | +0.0% | +0.0% | +764.9% | +0.0% | +0.0% | -5.3% |
| YoY Change | — | — | — | — | -29.7% | -38.0% | -5.7% | -5.7% | -25.0% | -25.0% | -25.0% | -25.0% | +23.0% | -46.0% | -46.0% | -46.0% | +279.9% | +764.9% | +764.9% | +719.1% |
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is Boston Scientific's indefinite-lived research and development assets?
- Boston Scientific (BSX) reported indefinite-lived research and development assets of $770.00M in Q1 2026.
- How has Boston Scientific's indefinite-lived research and development assets changed year-over-year?
- Boston Scientific's indefinite-lived research and development assets increased by 719.1% year-over-year, from $94.00M to $770.00M.
- What is the long-term trend for Boston Scientific's indefinite-lived research and development assets?
- Over 5 years (2020 to 2025), Boston Scientific's indefinite-lived research and development assets has grown at a 16.6% compound annual growth rate (CAGR), from $377.00M to $813.00M.
- What does indefinite-lived research and development assets mean?
- The value of ongoing research projects acquired from other companies that are not yet ready for sale.